Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003568priorityCriticalpatent/ECSP003568A/en
Publication of ECSP003568ApublicationCriticalpatent/ECSP003568A/en
Preparados de disgregación rápida que contienen al menos un principio activo farmacéutico y al menos un coadyuvante se obtienen por un procedimiento sencillo, en el que al menos la mayoría de la masa total de los ingredientes se granula para obtener el preparado, el granulado obtenido y dado el caso el resto de los ingredientes se conforman casi sin presión en presencia de líquido y los cuerpos conformados obtenidos se secan.Rapidly disintegrating preparations containing at least one pharmaceutical active ingredient and at least one adjuvant are obtained by a simple procedure, in which at least the majority of the total mass of the ingredients is granulated to obtain the preparation, the granules obtained and given In this case, the rest of the ingredients are formed almost without pressure in the presence of liquid and the shaped bodies obtained are dried.
ECSP0035682000-07-072000-07-07
PROCEDURE FOR OBTAINING SOLID PHARMACEUTICAL PREPARATIONS FOR QUICK DISGREGATION
ECSP003568A
(en)
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A 100 MG / ML HYDROSOLUBILITY, AND PROCEDURES FOR PREPARATION
Granules which contain high content of L-carnitine or an alkanoyl L-carnitine and which are particularly suitable for the preparation of tablets by direct pressing
FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND AN ANTAGONIST OF THE CALCIUM CHANNELS, PROCEDURE FOR ITS PREPARATION AND USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.